$116.86
6.535.92%
At Close: -
$116.86
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Silicon Laboratories
SLABNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Silicon Laboratories (NASDAQ:SLAB) Stock, Analyst Ratings, Price Targets, Forecasts
Silicon Laboratories Inc has a consensus price target of $153.75 based on the ratings of 16 analysts. The high is $208 issued by Morgan Stanley on December 15, 2021. The low is $86 issued by Morgan Stanley on November 2, 2023. The 3 most-recent analyst ratings were released by Citigroup, Barclays, and JP Morgan on April 25, 2024, respectively. With an average price target of $130 between Citigroup, Barclays, and JP Morgan, there's an implied 11.24% upside for Silicon Laboratories Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Barclays
JP Morgan
Needham
Stifel
1calculated from analyst ratings
Analyst Ratings for Silicon Laboratories
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/25/2024 | Buy Now | 2.69% | Citigroup | Atif Malik | $137 → $120 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | 2.69% | Barclays | Blayne Curtis | $140 → $120 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | Buy Now | 28.36% | JP Morgan | Peter Peng | $165 → $150 | Maintains | Overweight | Get Alert |
| 04/25/2024 | Buy Now | — | Benchmark | Cody Acree | — | Reiterates | → Hold | Get Alert |
| 04/25/2024 | Buy Now | 28.36% | Needham | Quinn Bolton | → $150 | Upgrade | Hold → Buy | Get Alert |
| 02/08/2024 | Buy Now | 19.8% | Barclays | Blayne Curtis | $120 → $140 | Maintains | Equal-Weight | Get Alert |
| 02/08/2024 | Buy Now | 41.19% | JP Morgan | Peter Peng | $145 → $165 | Maintains | Overweight | Get Alert |
| 01/16/2024 | Buy Now | 2.69% | Barclays | Blayne Curtis | $80 → $120 | Maintains | Equal-Weight | Get Alert |
| 01/02/2024 | Buy Now | 32.64% | Stifel | Tore Svanberg | $136 → $155 | Maintains | Buy | Get Alert |
| 12/08/2023 | Buy Now | 24.08% | JP Morgan | Peter Peng | → $145 | Initiates | → Overweight | Get Alert |
| 11/02/2023 | Buy Now | -26.41% | Morgan Stanley | Craig Hettenbach | $110 → $86 | Maintains | Equal-Weight | Get Alert |
| 11/02/2023 | Buy Now | 11.24% | Keybanc | John Vinh | $180 → $130 | Maintains | Overweight | Get Alert |
| 11/02/2023 | Buy Now | — | Barclays | Blayne Curtis | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/30/2023 | Buy Now | -5.87% | Morgan Stanley | Craig Hettenbach | $154 → $110 | Maintains | Equal-Weight | Get Alert |
| 10/19/2023 | Buy Now | 45.47% | Stifel | Tore Svanberg | $186 → $170 | Maintains | Buy | Get Alert |
| 07/31/2023 | Buy Now | 26.65% | Citigroup | Atif Malik | $165 → $148 | Maintains | Neutral | Get Alert |
| 07/27/2023 | Buy Now | 31.78% | Morgan Stanley | Craig Hettenbach | $159 → $154 | Maintains | Equal-Weight | Get Alert |
| 07/27/2023 | Buy Now | 54.03% | Keybanc | John Vinh | $200 → $180 | Maintains | Overweight | Get Alert |
| 07/07/2023 | Buy Now | — | Raymond James | Srini Pajjuri | — | Initiates | → Market Perform | Get Alert |
| 05/31/2023 | Buy Now | 41.19% | Citigroup | Atif Malik | $186 → $165 | Maintains | Neutral | Get Alert |
| 04/27/2023 | Buy Now | 36.06% | Morgan Stanley | Craig Hettenbach | $207 → $159 | Maintains | Equal-Weight | Get Alert |
| 04/27/2023 | Buy Now | 54.03% | TD Cowen | Matthew Ramsay | $200 → $180 | Maintains | Outperform | Get Alert |
| 04/27/2023 | Buy Now | 71.14% | Keybanc | John Vinh | $210 → $200 | Maintains | Overweight | Get Alert |
| 02/07/2023 | Buy Now | 59.16% | Citigroup | Atif Malik | $150 → $186 | Maintains | Neutral | Get Alert |
| 02/02/2023 | Buy Now | 62.59% | Wells Fargo | Gary Mobley | $155 → $190 | Maintains | Overweight | Get Alert |
| 02/02/2023 | Buy Now | 71.14% | Cowen & Co. | Matthew Ramsay | $175 → $200 | Maintains | Outperform | Get Alert |
| 02/02/2023 | Buy Now | 77.14% | Morgan Stanley | Craig Hettenbach | $151 → $207 | Maintains | Equal-Weight | Get Alert |
| 02/02/2023 | Buy Now | — | Summit Insights Group | Kinngai Chan | — | Upgrade | Hold → Buy | Get Alert |
| 02/02/2023 | Buy Now | 79.7% | Keybanc | John Vinh | $160 → $210 | Maintains | Overweight | Get Alert |
| 01/23/2023 | Buy Now | -14.43% | Barclays | Blayne Curtis | $85 → $100 | Maintains | Underweight | Get Alert |
| 01/09/2023 | Buy Now | 32.64% | Wells Fargo | Gary Mobley | $145 → $155 | Maintains | Overweight | Get Alert |
| 10/27/2022 | Buy Now | -27.26% | Barclays | Blayne Curtis | $95 → $85 | Maintains | Underweight | Get Alert |
| 10/27/2022 | Buy Now | 29.21% | Morgan Stanley | Craig Hettenbach | $161 → $151 | Maintains | Equal-Weight | Get Alert |
| 10/27/2022 | Buy Now | — | Needham | Rajvindra Gill | — | Downgrade | Buy → Hold | Get Alert |
| 10/27/2022 | Buy Now | 36.92% | Keybanc | John Vinh | $180 → $160 | Maintains | Overweight | Get Alert |
| 10/24/2022 | Buy Now | -18.71% | Barclays | Blayne Curtis | $140 → $95 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/28/2022 | Buy Now | 37.77% | Morgan Stanley | Craig Hettenbach | $156 → $161 | Maintains | Equal-Weight | Get Alert |
| 07/28/2022 | Buy Now | — | Summit Insights Group | Kinngai Chan | — | Downgrade | Buy → Hold | Get Alert |
| 07/28/2022 | Buy Now | 41.19% | Needham | Rajvindra Gill | $150 → $165 | Maintains | Buy | Get Alert |
| 07/11/2022 | Buy Now | 45.47% | Wells Fargo | Gary Mobley | $190 → $170 | Maintains | Overweight | Get Alert |
| 04/28/2022 | Buy Now | 105.37% | Needham | Rajvindra Gill | $230 → $240 | Maintains | Buy | Get Alert |
| 04/28/2022 | Buy Now | 54.03% | Keybanc | John Vinh | $210 → $180 | Maintains | Overweight | Get Alert |
| 04/25/2022 | Buy Now | 33.49% | Morgan Stanley | Joseph Moore | $208 → $156 | Maintains | Equal-Weight | Get Alert |
| 03/07/2022 | Buy Now | 96.82% | Needham | Rajvindra Gill | $210 → $230 | Maintains | Buy | Get Alert |
| 12/21/2021 | Buy Now | 92.54% | Wells Fargo | Gary Mobley | $190 → $225 | Maintains | Overweight | Get Alert |
| 12/15/2021 | Buy Now | 77.99% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
| 11/12/2021 | Buy Now | 92.54% | Stifel | Tore Svanberg | — | Maintains | Buy | Get Alert |
| 10/28/2021 | Buy Now | 64.3% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
| 10/28/2021 | Buy Now | 36.92% | Barclays | Blayne Curtis | — | Maintains | Equal-Weight | Get Alert |
| 10/28/2021 | Buy Now | 79.7% | Needham | Rajvindra Gill | — | Maintains | Buy | Get Alert |
| 10/28/2021 | Buy Now | 79.7% | Keybanc | John Vinh | — | Maintains | Overweight | Get Alert |
| 07/29/2021 | Buy Now | 30.93% | Morgan Stanley | Craig Hettenbach | — | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Silicon Laboratories (SLAB) stock?
The latest price target for Silicon Laboratories (NASDAQ:SLAB) was reported by Citigroup on April 25, 2024. The analyst firm set a price target for $120.00 expecting SLAB to rise to within 12 months (a possible 2.69% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Silicon Laboratories (SLAB)?
The latest analyst rating for Silicon Laboratories (NASDAQ:SLAB) was provided by Citigroup, and Silicon Laboratories maintained their neutral rating.
When was the last upgrade for Silicon Laboratories (SLAB)?
The last upgrade for Silicon Laboratories Inc happened on April 25, 2024 when Needham raised their price target to $150. Needham previously had a hold for Silicon Laboratories Inc.
When was the last downgrade for Silicon Laboratories (SLAB)?
The last downgrade for Silicon Laboratories Inc happened on October 27, 2022 when Needham changed their price target from N/A to N/A for Silicon Laboratories Inc.
When is the next analyst rating going to be posted or updated for Silicon Laboratories (SLAB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Silicon Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Silicon Laboratories was filed on April 25, 2024 so you should expect the next rating to be made available sometime around April 25, 2025.
Is the Analyst Rating Silicon Laboratories (SLAB) correct?
While ratings are subjective and will change, the latest Silicon Laboratories (SLAB) rating was a maintained with a price target of $137.00 to $120.00. The current price Silicon Laboratories (SLAB) is trading at is $116.86, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.